MONTREAL--(BUSINESS WIRE)--Ability Biologics (“Ability” or “the company”) announced the closing of its $12 million (US) financing round led by founding investor Amplitude Ventures. Amplitude is joined ...
Immuto CEO Faraz Choudhury spoke with Pharmaceutical Executive about his company’s work with focusing on Surface Protein Conformations (SPCs) for target discovery. According to him, traditional target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results